1Tuerk C,Gold L.Systematic evolution of ligands by exponential enrichment:RNA ligands to bacteriophage T4 DNA polymerase.Science,1990,249(4968):505-510.
2Kim S,Kim JH,Jeon O,et al.Engineered polymers for advanced drug delivery.Eur J Pharm Biopharm,2009,71(3):420-430.
3Parker N,Turk MJ,Westrick E,et al.Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay.Anal Biochem,2005,338(2):284-293.
4Yuan Y,Nymoen DA,Dong HP,et al.Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions.Hum Pathol,2009,40(10):1453-1460.
5Shangguan D,Meng L,Cao ZC,et al.Identification of liver cancer-specific aptamers using whole live cells.Anal Chem,2008,80(3):721-728.
6Raddatz MS,Dolf A,Endl E,et al.Enrichment of cell-targeting and population-specific aptamers by fluorascence-activated cell sorting.Angew Chem Int Ed Engl,2008,47(28):5190-5193.
7Lou X,Qian J,Xiao Y,et al.Micromagnetic selection of aptamets in microfluidic channels.Proc Natl Acad Sci U S A,2009,106(9):2989-2994.
8Nimjee SM,Rusconi CP,Sullenger BA.Aptamers:an emerging class of therapeutics.Annu Rev Med,2005,56:555-583.
9Keefe AD,Cload ST.SELEX with modified nucleotides.Curr Opin Chem Biol,2008,12(4):448-456.
10Nery AA,Wrenger C,Ulrich H.Recognition of biomarkers and cell-specific molecular signatures:aptamers as capture agents.J Sep Sci,2009,32(10):1523-1530.
